Pathophysiology of pulmonary function anomalies in COVID-19 survivors
Coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the predisposing and protecting factors have not been fully elucidated. COVID-19 primarily impacts the respiratory system, and can result in mild illness o...
Saved in:
Main Authors: | Pierantonio Laveneziana, Lucile Sesé, Thomas Gille |
---|---|
Format: | article |
Language: | EN |
Published: |
European Respiratory Society
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/04d3c8bcbbe445dfbce6d0a55cb83b81 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
by: A. Marques
Published: (2021) -
Pulmonary function testing in COPD: looking beyond the curtain of FEV1
by: Sotirios Kakavas, et al.
Published: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
by: Jafar Aljazeeri, et al.
Published: (2021) -
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
by: Massimo Girardis, et al.
Published: (2021) -
Periodontal Diseases: Major Exacerbators of Pulmonary Diseases?
by: Bakey Kouanda, et al.
Published: (2021)